▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Range Resources Q3 21 Earnings Conference Call At 9:00 AM ET

By RTTNews Staff Writer ✉ | Published: 10/27/2021 8:00 AM ET

Range Resources Corp. (RRC) will host a conference call at 9:00 AM ET on October 26, 2021, to discuss Q3 21 earnings results.

To access the live webcast, log on to https://ir.rangeresources.com/news-and-events/webcasts

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In February 2022 non small cell lung cancer chemotherapy

Biotech Stocks Facing FDA Decision In February 2022

Latest Updates on COVID-19

Pfizer Signs $3.2 Bln COVID Vaccine Deal With US Government

18K New Covid Cases, 144 Deaths In US

184K New Covid Cases, 860 Deaths In U.S.

FDA Experts Recommend Updated Booster Shots To Fight Contagious Omicron Variant In Fall

Sanofi-GSK Reports Positive Data From COVID-19 Beta-containing Vaccine Trial

Read More

COVID-19: Drugs in Development

RELATED NEWS

Range Resources Q1 22 Earnings Conference Call At 9:00 AM ET

Range Resources Corp. Q1 Earnings Summary

Follow RTT

Editor's Pick
Most Read
Most Emailed

Pfizer Signs $3.2 Bln COVID Vaccine Deal With US Government

Samsung Starts Mass Production Of Most Advanced 3-nm Chips

Morphine Sulfate Extended-Release Tablets Recalled Due To Label-Mix Up

FTC Sues Walmart For Facilitating Money Transfer Fraud

Bed Bath & Beyond Q1 Results Miss Estimates

Tesla Cuts 200 Autopilot Jobs, Closes San Mateo Office

FDA Experts Recommend Updated Booster Shots To Fight Contagious Omicron Variant In Fall

Creminelli Recalls Mini Parmesan Salami Stick Products

FDA Proposes Rule To Advance Consumer Access To OTC Drugs

US To Get 21 Mln Bottles Of Bellamy's Organic Infant Formula From Australia

Flight Cancellations, Delays On The Rise In US

FSIS Warns Against Ineligible Siluriformes Products Imported From Korea

Novavax's Prototype Vaccine Shows Broad Immune Responses Incl. Against Omicron And Other Variants

Antengene, BeiGene To Evaluate Selinexor Combination In T And NK-Cell Lymphoma

FDA Proposes Rule To Advance Consumer Access To OTC Drugs

Kezar Life Sciences Stock Surges 105% On Positive Data Drug Trial Results

Pfizer, BioNTech Report Positive Data From Omicron-adapted COVID-19 Vaccine Candidate Trial

FDA Places Clinical Hold On Astellas' Phase 1/2 Trial Of AT845 In Late-Onset Pompe Disease

US To Get 21 Mln Bottles Of Bellamy's Organic Infant Formula From Australia

Stanley Black & Decker To Divest Oil & Gas Business To Pipeline Technique

General Mills Gains On Upbeat Q4 Results, Increased Dividend

TD SYNNEX Q2 Results Top Estimates; Reaffirms FY22 Adj. EPS Outlook

Alaunos Extends Cooperative Research And Development Agreement With NCI

Ionis : GSK Presents Positive Phase 2b Data For Chronic Hepatitis B Treatment

China's Sinovac COVID-19 Vaccine CoronaVac Registered For Use In South Africa

Walgreens Boots Alliance, Inc. Q3 Profit Decreases, but beats estimates

Plusgrade Completes Acquisition Of Points.com

Jadestone Energy Appoints Bert-Jaap Dijkstra As New CFO

McDonald's Appoints Ian Borden To Succeed Kevin Ozan As CFO

Shoe Zone Sees FY22 Adj. Pretax Profit Not Less Than £8.5 Mln, Margin Growth; Stock Up

Keller Group Sees Full-year Performance Inline, Bags Order From S.Arabia 's NEOM Giga Project

Virgin Money UK To Repurchase 75 Mln Pounds Of Shares

Occidental Petroleum Up As Warren Buffett Adds Stock

Stagecoach FY Adj. Pretax Profit Rises

Ascletis' ASC22 Shows Potential Of Functional Cure Of Chronic Hepatitis B In Phase IIb Trial

Barnes & Noble Education, Inc. Q4 Loss Decreases